rituximab

(redirected from Mabthera)
Also found in: Medical.

ri·tux·i·mab

 (rĭ-tŭk′sĭ-măb′)
n.
A chimeric monoclonal antibody used to treat certain types of non-Hodgkin lymphoma, chronic lymphocytic leukemia, and refractory rheumatoid arthritis.

[ri-, origin unknown + tu(mor) + -xi- (alteration of chi(meric), influenced by X, Greek letter chi) + m(onoclonal) a(nti)b(ody).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

rituximab

(rɪˈtʌksɪˌmæb)
n
a monoclonal antibody used to treat non-Hodgkin's lymphoma
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

rituximab

n rituximab m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
In 2017, the FDA approved "Breakthrough Designation" status to MabThera (F.
Provided the proposed studies provide sufficient evidence, an extrapolation for all approved indications of MabThera (a brand name of rituximab) can be considered.
With Truxima, Celltrion expects to overtake the sales of Roche's Rituxan, which is also sold under the name MabThera.
The Jordan-based drugmaker agreed on the licensing deal with Celltrion to market the South Korea-based biopharmaceutical firm's Truxima, a copy of Roche's blockbuster blood cancer medicine, also known as MabThera. Truxima, the first biosimilar cancer drug to hit the European market in February, is used to treat patients with non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis and microscopic polyangiitis.
She successfully redesigned a portion of MabThera, an FDA-approved drug used to treat certain autoimmune diseases and types of cancer, into a new molecule to treat ALS.
I cannot forget the account of a lymphoma patient when I was training in the Philippine General Hospital: The patient's family members would fly to India just to buy Mabthera (Rituximab); it was cheaper to go there-airfare and all-and buy the drug for around P30,000 a vial, than to buy the same vial here for P90,000.
At the time, Fiona was apprehensive at the prospect of becoming a guinea pig for the revolutionary MabThera rituximab drug, but said she had to do it for both her and her daughter.
The full cost of the Mabthera injection Ahmad's wife receives every three weeks costs about YR380,000 ($1,800), but with the help of the NCCF Ahmad is able to pay YR200,000 ($1000) instead.
Diez medicamentos mas comercializados (a) en Ecuador en el periodo 2011-2012 (se mencionan las marcas registradas) Productos comercializados Productos comercializados con receta medica sin receta medica 2011 2012 2011 2012 1 Lipitor Seretide Ensure Arcoxia 2 Plavix Humira Apronax Kufer Q 3 Seretide Crestor Pharmaton Complejo B 4 Crestor Nexium Pediasure Fluimucil 5 Nexium Enbrel Mesygina Mesulid 6 Seroquel Remicade Neurobion Omezzol 7 Humira Abilify Mesulid Neurobion 8 Enbrel Lantux Arcoxia Doloneurobion 9 Remicade Mabthera Aspirina Abrilar 10 Abilify Cymbalta Unasyn Mesigina Fuente: IMS 2011(20).
The procedure involves the injection of antibody MabThera (rituximab), which will now take less than 15 minutes to administer under the skin.
Mabthera batches, B60360, B60420, B60480, B60490, B6074B04, and B6083, were obtained from F.